To address global concerns and needs in supporting immune health more effectively, Royal DSM has launched ampli-D, a fast-acting form of vitamin D for dietary supplements in Asia-Pacific, with Australia as the first market. Ampli-D will be released in Singapore next and the rest of South-east Asia before broader release across the other countries in Asia-Pacific.
Ampli-D is calcifediol, a form of vitamin D found in the human body and blood stream.
Following approval by Australia’s Therapeutic Goods Administration (TGA), ampli-D is available as an ingredient to manufacturers of health supplements. In addition, DSM has also launched its own dietary supplement product with ampli-D in tablet form for Australian consumers, branded as Fortaro.
Dr Taichi Inui, Asia-Pacific regional manager for nutrition science and advocacy at DSM Nutrition Products, explained: “In the human body, vitamin D needs to be processed by the liver and converted into calcifediol to be processed further in the kidneys. The whole process is slow, and it can easily take several months to achieve healthy levels in the bloodstream. With ampli-D, calcifediol the common form of vitamin D in the body is now also available as a dietary supplement and helps the body get to optimal vitamin D levels in weeks instead of months.”
Depending on an individual’s lifestyle, obtaining sufficient levels of vitamin D in the body can be challenging due to limited food sources and a person’s direct exposure to sunlight. Even with an intake of traditional vitamin D supplements like D3 or fortified food, it can still take several months to achieve healthy vitamin D levels in the bloodstream, which supports areas as one of the top three health concerns.
Anand Sundaresan, vice-president, human nutrition and health, Asia-Pacific, DSM, concluded: “Supporting our immune health is essential throughout our lives and recent developments make it more important than ever before to prioritise immune health through nutrition. Our global launch of ampli-D, with Australia the first country to approve the product, shows how we are accelerating accessibility towards nutritional solutions by making it market-ready for our customers and partners and available for consumers.”
